Evidence map›Paper›PMID 34360009›Full record

ArticleCells2021

Transcriptomic Profile Reveals Deregulation of Hearing-Loss Related Genes in Vestibular Schwannoma Cells Following Electromagnetic Field Exposure.

Alessandra Colciago, Matteo Audano, Veronica Bonalume, Valentina Melfi, Tasnim Mohamed, Adam J Reid, Alessandro Faroni, Peter A Greer, Nico Mitro, Valerio Magnaghi

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Alessandra ColciagoDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.ORCID 0000-0001-6281-514X
Matteo AudanoDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.ORCID 0000-0003-2791-4526
Veronica BonalumeDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.ORCID 0000-0002-1185-2351
Valentina MelfiDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.ORCID 0000-0001-5289-9618
Tasnim MohamedDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.
Adam J ReidBlond McIndoe Laboratories, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9NQ, UK.ORCID 0000-0003-1752-3302
Alessandro FaroniBlond McIndoe Laboratories, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9NQ, UK.ORCID 0000-0003-4435-6423
Peter A GreerDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
Nico MitroDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.ORCID 0000-0002-5000-3619
Valerio MagnaghiDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Via G. Balzaretti 9, 20133 Milan, Italy.ORCID 0000-0002-6903-7042
University of Milan · ITManchester Academic Health Science Centre · GBQueen's University · CA

Funding

Capita Foundation grant 2019 to V.M.MIUR Italian Ministry of Research Progetto di EccellenzaUniversità degli Studi di Milano grant PSR_VMAGN_2019 to V.M
6 · The paper itself

Abstract

Hearing loss (HL) is the most common sensory disorder in the world population. One common cause of HL is the presence of vestibular schwannoma (VS), a benign tumor of the VIII cranial nerve, arising from Schwann cell (SC) transformation. In the last decade, the increasing incidence of VS has been correlated to electromagnetic field (EMF) exposure, which might be considered a pathogenic cause of VS development and HL. Here, we explore the molecular mechanisms underlying the biologic changes of human SCs and/or their oncogenic transformation following EMF exposure. Through NGS technology and RNA-Seq transcriptomic analysis, we investigated the genomic profile and the differential display of HL-related genes after chronic EMF. We found that chronic EMF exposure modified the cell proliferation, in parallel with intracellular signaling and metabolic pathways changes, mostly related to translation and mitochondrial activities. Importantly, the expression of HL-related genes such as NEFL, TPRN, OTOGL, GJB2, and REST appeared to be deregulated in chronic EMF exposure. In conclusion, we suggest that, at a preclinical stage, EMF exposure might promote the transformation of VS cells and contribute to HL.

Indexed as

TranscriptomeCell MovementCell ProliferationCell SurvivalConnexin 26Electromagnetic FieldsGene Expression ProfilingGene Expression RegulationHearing LossHumansMembrane ProteinsNeurofilament ProteinsNeuroma, AcousticPrimary Cell CultureProteinsRE1-Silencing Transcription FactorConnexin 26GJB2 protein, humanMembrane Proteinsneurofilament protein LNeurofilament ProteinsOTOGL protein, humanProteinsRE1-Silencing Transcription FactorRepressor ProteinsTPRN protein, humanGJB2hearing lossNEFLNF2OTOGLRESTSchwann cellTPRN

Identifiers

PMID34360009
PMCPMC8307028
OpenAlexW3183359877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.